MNOV
Closed
Medicinova Inc
1.27
-0.04 (-3.05%)
Last Update: 01 Jul 2025 23:00:00
Yesterday: 1.31
Day's Range: 1.27 - 1.32
Send
sign up or login to leave a comment!
When Written:
2.2
MediciNova Inc is a biopharmaceutical company that develops and commercializes novel, small-molecule therapeutics for the treatment of diseases with unmet medical needs. The company's pipeline includes potential treatments for multiple sclerosis, acute exacerbations of asthma, fibrosis, and other diseases. MediciNova's lead candidate is ibudilast, which is being developed for the treatment of multiple sclerosis and amyotrophic lateral sclerosis (ALS). The company is headquartered in La Jolla, California, and was founded in 2000.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!








